论文部分内容阅读
室性心动过速(VT)是临床常见的危重症之一。对某些药物难以控制的室速以往多采用腔内电生理的方法诊断及治疗,或电击复律。1969年 Burack 首创经食管心室起搏。近年周德麟报告经食管心室起搏(TEVP)治疗药物难治性室速有良好效果。我院近年对3例顽固性室速进行4例次 TEVP,体会到 TEVP不仅可以终止室速而且有助于分析判断某些室速的发生机制,为选择预防性药物提供依据。
Ventricular tachycardia (VT) is one of the most common critically ill patients. For some drugs difficult to control the ventricular tachycardia in the past the use of intracavitary electrophysiological methods of diagnosis and treatment, or cardioversion. 1969 Burack pioneered transesophageal pacing. In recent years, Zhou Delin reported esophageal ventricular pacing (TEVP) treatment of refractory ventricular tachycardia with good results. In our hospital in recent years, 3 cases of intractable ventricular tachycardia TEVP, experience TEVP can not only terminate the VT but also help to analyze and determine the mechanism of certain VT, to provide a basis for the selection of preventive drugs.